Vireo Growth (VREOF) Restructuring Costs (2020 - 2026)
Vireo Growth's (VREOF) quarterly Restructuring Costs came in at $7.2 million in Q1 2026, up 620.0% year-on-year from $1.0 million in Q1 2025, and up 18.37% quarter-over-quarter from $6.1 million in Q4 2025.
Vireo Growth (VREOF) Restructuring Costs (2020 - 2026) Analysis & Trends
Vireo Growth has disclosed Restructuring Costs across 7 years of filings, most recently posting $7.2 million for Q1 2026.
- Restructuring Costs for Q1 2026 came in at $7.2 million, up 620.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $27.4 million (up 554.91% YoY), and the FY2025 annual result was $20.4 million, up 351.83% from the prior year.
- Restructuring Costs came in at $7.2 million for Q1 2026 at Vireo Growth, up from $6.1 million in the prior quarter.
- In the past five years, Restructuring Costs ranged from a high of $9.4 million in Q3 2025 to a low of $182602.0 in Q4 2024.
- The 5-year median for Restructuring Costs is $1.6 million (2023), against an average of $2.7 million.
- Across the five-year window, Restructuring Costs tumbled 79.7% in 2024 and surged 3231.21% in 2025, its largest moves.
- Vireo Growth's Restructuring Costs stood at $1.5 million in 2022, then tumbled by 40.58% to $899519.0 in 2023, then sank by 79.7% to $182602.0 in 2024, then soared by 3231.21% to $6.1 million in 2025, then climbed by 18.37% to $7.2 million in 2026.
- The last three Restructuring Costs figures came in at $7.2 million (Q1 2026), $6.1 million (Q4 2025), and $9.4 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn |
| 10 | Vireo Growth | - | - | 59.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7.20 Mn |
| Dec 31, 2025 | 6.08 Mn |
| Sep 30, 2025 | 9.39 Mn |
| Jun 30, 2025 | 4.73 Mn |
| Mar 31, 2025 | 1.00 Mn |
| Dec 31, 2024 | 182,602.00 |
| Sep 30, 2024 | 1.57 Mn |
| Jun 30, 2024 | 1.43 Mn |
| Mar 31, 2024 | 1.32 Mn |
| Dec 31, 2023 | 899,519.00 |
| Sep 30, 2023 | 1.40 Mn |
| Jun 30, 2023 | 1.59 Mn |
| Mar 31, 2023 | 1.61 Mn |
| Dec 31, 2022 | 1.51 Mn |
| Sep 30, 2022 | 1.84 Mn |
| Jun 30, 2022 | 2.10 Mn |
| Mar 31, 2022 | 1.95 Mn |
| Dec 31, 2021 | 1.75 Mn |
| Sep 30, 2021 | 2.06 Mn |
| Jun 30, 2021 | 2.34 Mn |